Journal ArticleProstate · September 2024
PURPOSE: To compare the efficacy of a novel fusion template "reduced six-core systemic template and multiparametric magnetic resonance imaging/transrectal ultrasound (mpMRI/TRUS) fusion targeted biopsy" (TBx+6c), with mpMRI/TRUS fusion-targeted biopsy and ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · August 21, 2024
OBJECTIVE: A deep neural network (DNN) was trained to generate a multiparametric ultrasound (mpUS) volume from four input ultrasound-based modalities (acoustic radiation force impulse [ARFI] imaging, shear wave elasticity imaging [SWEI], quantitative ultra ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · August 12, 2024
IMPORTANCE AND OBJECTIVE: Partial gland ablation (PGA) is increasingly popular as a treatment for men with intermediate-risk prostate cancer (IR-PCa) to preserve functional outcomes while controlling their cancer. We aimed to determine the impact of race a ...
Full textLink to itemCite
Journal ArticleNanomaterials · August 1, 2024
AuroLase® Therapy—a nanoparticle-enabled focal therapy—has the potential to safely and effectively treat localized prostate cancer (PCa), preserving baseline functionality. This article presents a detailed case of localized PCa treated with AuroLase, provi ...
Full textCite
Journal ArticleCancers (Basel) · June 8, 2024
The PRESERVE study (NCT04972097) aims to evaluate the safety and effectiveness of the NanoKnife System to ablate prostate tissue in patients with intermediate-risk prostate cancer (PCa). The NanoKnife uses irreversible electroporation (IRE) to deliver high ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · June 2024
BACKGROUND: Prostate cancer (PCa) diagnosis relies on biopsies, with transrectal ultrasound (TRUS) biopsies being common. Fusion biopsy (FB) offers improved diagnostic accuracy, but the pain and anxiety experienced by patients during biopsies is often over ...
Full textLink to itemCite
Journal ArticleNat Rev Urol · May 2024
Major advances have been made in the use of immunotherapy for the treatment of solid tumours, including the use of intratumourally injected immunotherapy instead of systemically delivered immunotherapy. The success of immunotherapy in prostate cancer treat ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
The lack of accuracy in the current prostate specific antigen (PSA) test for prostate cancer (PCa) screening causes around 60-75% of unnecessary prostate biopsies. Therefore, alternative diagnostic methods that have better accuracy and can prevent over-dia ...
Full textLink to itemCite
Journal ArticleProstate Cancer and Prostatic Diseases · January 1, 2024
Background: Certain widely used pathological outcome prediction models that were developed in tertiary centers tend to overpredict outcomes in the community setting; thus, the Michigan Urological-Surgery Improvement Collaborative (MUSIC) model was develope ...
Full textCite
Journal ArticleCancers (Basel) · December 18, 2023
Recurrent prostate cancer after primary treatment with radiation therapy is a common problem. Patients with localized recurrence may benefit from salvage therapy, but careful patient selection is crucial because not all patients will benefit from local sal ...
Full textLink to itemCite
Journal ArticleEur Urol · December 2023
CONTEXT: Whole-gland ablation is a feasible and effective minimally invasive treatment for localized prostate cancer (PCa). Previous systematic reviews supported evidence for favorable functional outcomes, but oncological outcomes were inconclusive owing t ...
Full textLink to itemCite
Journal ArticleEur J Radiol Open · December 2023
OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) surveillance post focal cryotherapy (FT) of prostate cancer is challenging as post treatment artefacts alter mpMRI findings. In this initial experience, we assessed diagnostic performance of mp ...
Full textLink to itemCite
Journal ArticleTransl Androl Urol · October 31, 2023
BACKGROUND: Androgen deprivation therapy (ADT), commonly delivered via a luteinizing hormone-releasing hormone (LHRH) agonist, is the standard treatment for advanced prostate cancer (PC). While quite effective, it has been associated with an increased risk ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · October 2023
INTRODUCTION: Local prostate cancer recurrence following radiotherapy (XRT) or cryoablation (CRYO) may be addressed with salvage cryotherapy (SCT), although little is known about how the primary treatment modality affects SCT results. Oncologic and functio ...
Full textLink to itemCite
Journal ArticleProstate · October 2023
BACKGROUND: Salvage cryotherapy (SCT) is widely used to treat prostate cancer (PCa) recurrence after radiotherapy (RT). We studied the intermediate oncological and functional outcomes of patients who underwent SCT following cryotherapy (CRYO-SCT) recurrenc ...
Full textLink to itemCite
Journal ArticleEur J Radiol · August 2023
PURPOSE: PI-RADS 4 lesions are considered to have a "high" likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing targeted biopsy have a range of histologic findings. Understanding discordant cases is critical to improve ...
Full textLink to itemCite
Journal ArticleWorld J Mens Health · July 2023
PURPOSE: Prostate cancer (PCa) screening can lead to potential over-diagnosis/over-treatment of indolent cancers. There is a need to optimize practices to better risk-stratify patients. We examined initial longitudinal outcomes of mid-life men with an elev ...
Full textLink to itemCite
Journal ArticleProstate · September 2024
PURPOSE: To compare the efficacy of a novel fusion template "reduced six-core systemic template and multiparametric magnetic resonance imaging/transrectal ultrasound (mpMRI/TRUS) fusion targeted biopsy" (TBx+6c), with mpMRI/TRUS fusion-targeted biopsy and ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · August 21, 2024
OBJECTIVE: A deep neural network (DNN) was trained to generate a multiparametric ultrasound (mpUS) volume from four input ultrasound-based modalities (acoustic radiation force impulse [ARFI] imaging, shear wave elasticity imaging [SWEI], quantitative ultra ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · August 12, 2024
IMPORTANCE AND OBJECTIVE: Partial gland ablation (PGA) is increasingly popular as a treatment for men with intermediate-risk prostate cancer (IR-PCa) to preserve functional outcomes while controlling their cancer. We aimed to determine the impact of race a ...
Full textLink to itemCite
Journal ArticleNanomaterials · August 1, 2024
AuroLase® Therapy—a nanoparticle-enabled focal therapy—has the potential to safely and effectively treat localized prostate cancer (PCa), preserving baseline functionality. This article presents a detailed case of localized PCa treated with AuroLase, provi ...
Full textCite
Journal ArticleCancers (Basel) · June 8, 2024
The PRESERVE study (NCT04972097) aims to evaluate the safety and effectiveness of the NanoKnife System to ablate prostate tissue in patients with intermediate-risk prostate cancer (PCa). The NanoKnife uses irreversible electroporation (IRE) to deliver high ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · June 2024
BACKGROUND: Prostate cancer (PCa) diagnosis relies on biopsies, with transrectal ultrasound (TRUS) biopsies being common. Fusion biopsy (FB) offers improved diagnostic accuracy, but the pain and anxiety experienced by patients during biopsies is often over ...
Full textLink to itemCite
Journal ArticleNat Rev Urol · May 2024
Major advances have been made in the use of immunotherapy for the treatment of solid tumours, including the use of intratumourally injected immunotherapy instead of systemically delivered immunotherapy. The success of immunotherapy in prostate cancer treat ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
The lack of accuracy in the current prostate specific antigen (PSA) test for prostate cancer (PCa) screening causes around 60-75% of unnecessary prostate biopsies. Therefore, alternative diagnostic methods that have better accuracy and can prevent over-dia ...
Full textLink to itemCite
Journal ArticleProstate Cancer and Prostatic Diseases · January 1, 2024
Background: Certain widely used pathological outcome prediction models that were developed in tertiary centers tend to overpredict outcomes in the community setting; thus, the Michigan Urological-Surgery Improvement Collaborative (MUSIC) model was develope ...
Full textCite
Journal ArticleCancers (Basel) · December 18, 2023
Recurrent prostate cancer after primary treatment with radiation therapy is a common problem. Patients with localized recurrence may benefit from salvage therapy, but careful patient selection is crucial because not all patients will benefit from local sal ...
Full textLink to itemCite
Journal ArticleEur Urol · December 2023
CONTEXT: Whole-gland ablation is a feasible and effective minimally invasive treatment for localized prostate cancer (PCa). Previous systematic reviews supported evidence for favorable functional outcomes, but oncological outcomes were inconclusive owing t ...
Full textLink to itemCite
Journal ArticleEur J Radiol Open · December 2023
OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) surveillance post focal cryotherapy (FT) of prostate cancer is challenging as post treatment artefacts alter mpMRI findings. In this initial experience, we assessed diagnostic performance of mp ...
Full textLink to itemCite
Journal ArticleTransl Androl Urol · October 31, 2023
BACKGROUND: Androgen deprivation therapy (ADT), commonly delivered via a luteinizing hormone-releasing hormone (LHRH) agonist, is the standard treatment for advanced prostate cancer (PC). While quite effective, it has been associated with an increased risk ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · October 2023
INTRODUCTION: Local prostate cancer recurrence following radiotherapy (XRT) or cryoablation (CRYO) may be addressed with salvage cryotherapy (SCT), although little is known about how the primary treatment modality affects SCT results. Oncologic and functio ...
Full textLink to itemCite
Journal ArticleProstate · October 2023
BACKGROUND: Salvage cryotherapy (SCT) is widely used to treat prostate cancer (PCa) recurrence after radiotherapy (RT). We studied the intermediate oncological and functional outcomes of patients who underwent SCT following cryotherapy (CRYO-SCT) recurrenc ...
Full textLink to itemCite
Journal ArticleEur J Radiol · August 2023
PURPOSE: PI-RADS 4 lesions are considered to have a "high" likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing targeted biopsy have a range of histologic findings. Understanding discordant cases is critical to improve ...
Full textLink to itemCite
Journal ArticleWorld J Mens Health · July 2023
PURPOSE: Prostate cancer (PCa) screening can lead to potential over-diagnosis/over-treatment of indolent cancers. There is a need to optimize practices to better risk-stratify patients. We examined initial longitudinal outcomes of mid-life men with an elev ...
Full textLink to itemCite
Journal ArticleUltrason Imaging · July 2023
This study demonstrates the implementation of a shear wave reconstruction algorithm that enables concurrent acoustic radiation force impulse (ARFI) imaging and shear wave elasticity imaging (SWEI) of prostate cancer and zonal anatomy. The combined ARFI/SWE ...
Full textLink to itemCite
Journal ArticleUrology · July 2023
OBJECTIVE: To assess Duke's experience on the utility of transperineal template mapping biopsy (TTMB) for re-evaluating patients with persistently elevated prostate-specific antigen after prior negative biopsy, with pre-existing prostate cancer (PCa) alrea ...
Full textLink to itemCite
Journal ArticleProstate · June 2023
INTRODUCTION: We report herein the impact of focal therapy (FT) on multi-domain functional outcomes in a Phase II prospective clinical trial (NCT04138914) in focal cryotherapy for clinically significant prostate cancer (csPCa). METHODS: The primary outcome ...
Full textLink to itemCite
Journal ArticleEur Urol Oncol · June 2023
BACKGROUND: There is no consensus on the optimal approach for salvage local therapy in radiation-resistant/recurrent prostate cancer (RRPC). OBJECTIVE: To investigate oncological and functional outcomes for men treated with salvage whole-gland cryoablation ...
Full textLink to itemCite
Journal ArticleCan J Urol · June 2023
INTRODUCTION: The clinical utility of concurrent Prostate Health Index (PHI) and ExosomeDx Prostate Intelliscore (EPI) testing is unclear. We sought to examine the performance of combined PHI and EPI testing on men undergoing elevated PSA work up. MATERIAL ...
Link to itemCite
ConferenceUrology · May 2023
OBJECTIVE: To assess how the validated Prostate Health Index (PHI) risk stratifications perform with African American (AA) men and establish a threshold PHI value to potentially rule out the need for prostate biopsy. MATERIALS AND METHODS: AA men meeting F ...
Full textLink to itemCite
Journal ArticleUrology · April 2023
OBJECTIVES: To assess the comparative safety and effectiveness of 2 prostate cancer treatment ablation modalities: irreversible electroporation (IRE) and high-intensity focused ultrasound (HIFU). METHODS: Two systematic literature reviews (SLRs) and meta- ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · March 2023
PURPOSE: Metastasis-free survival (MFS) is a surrogate for overall survival (OS) in men with non-metastatic castration-resistant prostate cancer (CRPC), but this endpoint may take years to develop in men with non-metastatic castrate-sensitive disease. The ...
Full textLink to itemCite
Journal ArticleMini-invasive Surgery · January 1, 2023
Renal cell carcinoma is identified most often in the sixth or seventh decade of life, coinciding with the rise in incidental diagnosis of small renal masses as imaging technology has advanced. However, not all patients in this older age group are surgical ...
Full textCite
Journal ArticleProstate · December 2022
BACKGROUND: Follicle stimulating hormone (FSH) is a pituitary hormone that helps regulate testosterone homeostasis. Although it is generally accepted that FSH levels increase with LHRH-agonist therapy for prostate cancer (PC), the specific impact of FSH le ...
Full textLink to itemCite
Journal ArticleCancer · November 1, 2022
BACKGROUND: This study reports the oncological and functional outcomes in men with localized prostate cancer (Pca) who were treated with primary whole gland cryoablation (WGC) of the prostate. METHODS: The authors retrospectively reviewed their prospective ...
Full textLink to itemCite
Journal ArticleUrol Clin North Am · November 2022
Despite newer therapies for castrate-resistant prostate cancer (CRPC), many patients do not experience a treatment response, and most eventually experience secondary resistance. Various androgen-receptor-related and alternative mechanisms of resistance in ...
Full textLink to itemCite
Journal ArticleMinerva Urol Nephrol · October 2022
BACKGROUND: Focal therapy (FT) for prostate cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following up men ...
Full textLink to itemCite
Journal ArticleEur Urol Oncol · October 2022
There is uncertainty with how to proceed when targeted prostate biopsy of suspicious multiparametric magnetic resonance imaging (mpMRI) lesions return without clinically significant prostate cancer (csPCa). While possible, there are error sources that coul ...
Full textLink to itemCite
Journal ArticleUrol Pract · September 2022
INTRODUCTION: Radium-223 was approved for metastatic castration-resistant prostate cancer based on the ALSYMPCA trial. We characterize radium-223 treatment patterns and overall survival (OS) in a large equal access health system. METHODS: We identified all ...
Full textLink to itemCite
Journal ArticleAbdom Radiol (NY) · August 2022
BACKGROUND: Prostate multiparametric magnetic resonance imaging (mpMRI) can identify lesions within the prostate with characteristics identified in Prostate Imaging Reporting and Data System (PI-RADS) v2.1 associated with clinically significant prostate ca ...
Full textLink to itemCite
Journal ArticleUrol Oncol · May 2022
INTRODUCTION AND OBJECTIVES: Cryoablation offers a treatment option for small renal masses ideally suited ≤3 cm. In well-selected candidates, it is associated with less perioperative morbidity compared to more invasive options, such as partial or radical n ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · May 1, 2022
PURPOSE OF REVIEW: To review assessment after focal therapy (FT) in the context of developments from the past two years. RECENT FINDINGS: With a paucity of high-quality studies, recent findings are primarily reliant on results from institutional-based coho ...
Full textLink to itemCite
Journal ArticleMol Cancer Ther · March 1, 2022
Prostate cancer remains the second leading cause of cancer death among American men. Radiotherapy is a potentially curative treatment for localized prostate cancer, and failure to control localized disease contributes to the majority of prostate cancer dea ...
Full textLink to itemCite
Journal ArticleEur Urol Open Sci · March 2022
BACKGROUND: Recent reports with a small number of patients showed an association of red blood cell distribution width (RDW) with prostate cancer (PCa) progression. OBJECTIVE: To investigate whether preoperative RDW can serve as a prognostic marker in patie ...
Full textLink to itemCite
Journal ArticleUrol Clin North Am · February 2022
Organ sparing approaches for the management of localized prostate cancer were developed in part to overcome the morbidity associated with standard, whole gland treatment options. The first description of focal therapy was now over two decades ago and since ...
Full textLink to itemCite
Journal ArticleAnn Clin Transl Neurol · February 2022
OBJECTIVE: Numerous investigators have theorized that postoperative changes in Alzheimer's disease neuropathology may underlie postoperative neurocognitive disorders. Thus, we determined the relationship between postoperative changes in cognition and cereb ...
Full textOpen AccessLink to itemCite
Journal ArticleInt Braz J Urol · 2022
PURPOSE: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated with significant number of serious s ...
Full textLink to itemCite
Journal ArticleMol Cancer Ther · January 2022
A noninvasive test to discriminate indolent prostate cancers from lethal ones would focus treatment where necessary while reducing overtreatment. We exploited the known activity of heat shock protein 90 (Hsp90) as a chaperone critical for the function of n ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · January 1, 2022
We have developed a 3D acoustic radiation force impulse (ARFI) imaging system that screens for prostate cancer and provides imaging guidance for a targeted biopsy in a single clinic visit. ARFI and B-mode volumes are acquired by using a rotation stage to s ...
Full textCite
Journal ArticleUrol Oncol · November 2021
BACKGROUND: With the advancement of imaging technology, focal therapy (FT) has been gaining acceptance for the treatment of select patients with localized prostate cancer (CaP). We aim to provide details of a formal physician consensus on the utilization o ...
Full textLink to itemCite
Journal ArticleJ Endourol · September 2021
Focal cryoablation of localized prostate cancer can offer patients superior genitourinary functional outcomes in terms of preservation of urinary continence and potency compared with radical whole-gland therapy, while maintaining intermediate-term oncologi ...
Full textLink to itemCite
Journal ArticleJournal of endourology · September 2021
Objectives: We aim at reporting the functional and oncological outcomes in men with localized prostate cancer who underwent individualized partial gland cryoablation of the prostate by using validated quality-of-life instruments. Method ...
Full textCite
Journal ArticleUrol Clin North Am · August 2021
Prostate cancer represents a significant health care burden in the United States due to its incidence, treatment-related morbidity, and cancer-specific mortality. The burden begins with prostate-specific antigen screening, which has been subject to controv ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · July 2021
Transrectal ultrasound (TRUS) B-mode imaging provides insufficient sensitivity and specificity for prostate cancer (PCa) targeting when used for biopsy guidance. Shear wave elasticity imaging (SWEI) is an elasticity imaging technique that has been commerci ...
Full textLink to itemCite
Journal ArticleIEEE Trans Ultrason Ferroelectr Freq Control · July 2021
Ultrasound elasticity imaging in soft tissue with acoustic radiation force requires the estimation of displacements, typically on the order of several microns, from serially acquired raw data A-lines. In this work, we implement a fully convolutional neural ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · June 2021
BACKGROUND: To assess whether prior interventional treatment for benign prostatic hyperplasia (BPH) influences oncologic or functional outcomes following primary whole-gland prostate cryoablation. METHODS: Among 3831 men with prostate cancer who underwent ...
Full textLink to itemCite
Journal ArticleCurr Urol · June 2021
BACKGROUND: This study aimed to compare the oncological and functional outcomes of primary whole gland cryoablation of the prostate using the variable ice cryoprobe (V-Probe®) and the conventional fixed-size ice probe. MATERIALS AND METHODS: We reviewed th ...
Full textLink to itemCite
Journal ArticleProstate · May 2021
BACKGROUND: Real-world utilization and outcomes of combination therapy for men with metastatic castrate-resistant prostate cancer (mCRPC) are largely unknown. We evaluated the overall survival (OS) and skeletal-related events (SREs) among men who received ...
Full textLink to itemCite
Journal ArticleWorld J Urol · March 2021
PURPOSE: To review the current evidence regarding protocols and outcomes of image-guided focal therapy (FT) for prostate cancer (PCa). METHODS: A literature search of the latest published studies assessing primary FT for PCa was carried out in Medline and ...
Full textLink to itemCite
ConferenceJ Gen Intern Med · January 2021
BACKGROUND: Implementation methods of risk-stratified cancer screening guidance throughout a health care system remains understudied. OBJECTIVE: Conduct a preliminary analysis of the implementation of a risk-stratified prostate cancer screening algorithm i ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · January 1, 2021
This study presents a deep neural network (DNN) for generating a multiparametric ultrasound (mpUS) volume of the prostate by combining data from acoustic radiation force impulse (ARFI) imaging, shear wave elasticity imaging (SWEI), B-mode imaging, and quan ...
Full textCite
Journal ArticleUrol Pract · January 2021
INTRODUCTION: Limited real-world data are available on treatment sequences for patients with metastatic hormone-sensitive prostate cancer treated with androgen deprivation therapy plus docetaxel or abiraterone who progress to castrate resistance. METHODS: ...
Full textLink to itemCite
Chapter · January 1, 2021
The aim of focal therapy for prostate cancer is targeted treatment of the clinically significant cancer foci to preserve the genitourinary function. In recent years, advances in training and safety measures have increased the clinical adoption of prostate ...
Full textCite
Journal ArticleUltrasound Med Biol · December 2020
Diagnosing prostate cancer through standard transrectal ultrasound (TRUS)-guided biopsy is challenging because of the sensitivity and specificity limitations of B-mode imaging. We used a linear support vector machine (SVM) to combine standard TRUS imaging ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · September 7, 2020
This study demonstrates the application of multiparametric ultrasound (mpUS) imaging techniques for combining data from four individual modalities: acoustic radiation force impulse (ARFI) imaging, shear wave elasticity imaging (SWEI), B-mode imaging, and q ...
Full textCite
Journal ArticleEur Urol · September 2020
BACKGROUND: Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by urologists and radiologists as an option for the management of localized prostate cancer. OBJECTIVE: To find consensus on a standardized nomenclature and to define a fol ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · August 20, 2020
PURPOSE: Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in GT in ...
Full textLink to itemCite
Journal ArticleJ Neurol · July 2020
OBJECTIVE: Lumbar punctures (LPs) are important for obtaining CSF in neurology studies but are associated with adverse events and feared by many patients. We determined adverse event rates and pain scores in patients prospectively enrolled in two cohort st ...
Full textLink to itemCite
Journal ArticleRadiology · July 2020
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps provide a standardized probabilistic approach for identifying clinically s ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · June 2020
BACKGROUND: We compared the short-term oncologic and functional outcomes of salvage focal cryotherapy (SFC) with those of salvage total cryotherapy (STC) for radiotherapy (RT)-persistent/recurrent prostate cancer. MATERIALS AND METHODS: We queried the Cryo ...
Full textLink to itemCite
Journal ArticleJ Endourol · April 2020
Objective: To define current trends in the utilization of renal thermal ablation by urologists in the United States. Material and Methods: A six-month case log data for renal procedures submitted by certifying and recertifying American urologists from 2003 ...
Full textLink to itemCite
Journal ArticleJ Urol · February 2020
PURPOSE: Several recent studies on metastatic castration resistant prostate cancer demonstrated improved overall survival in black vs white men. 223Radium is Food and Drug Administration approved for metastatic castration resistant prostate cancer based on ...
Full textLink to itemCite
Journal ArticleProstate Cancer and Prostatic Diseases · January 1, 2020
The authors hereby retract the e-publication dated 13 May 2008 and entitled, 'Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?' The authors are submitting a revised version w ...
Full textCite
Journal ArticleJ Alzheimers Dis · 2020
BACKGROUND: Perioperative neurocognitive disorders (PND) are common complications in older adults associated with increased 1-year mortality and long-term cognitive decline. One risk factor for worsened long-term postoperative cognitive trajectory is the A ...
Full textOpen AccessLink to itemCite
Chapter · January 1, 2020
Renal mass biopsy is a diagnostic technique that can be employed to evaluate the small renal mass (SRM); however, it remains underutilized to this day. The overall accuracy of percutaneous SRM biopsy is between 79% and 100%. The main shortcomings of renal ...
Full textCite
Journal ArticleBMC Urol · December 5, 2019
BACKGROUND: Due to their location away from the nerve bundles, anterior prostate cancers (APC) represent a rational target for image-guided cryoablation. This report describes the feasibility and short-term outcomes of anterior focal cryosurgery. METHODS: ...
Full textLink to itemCite
Journal ArticleJ Urol · November 2019
PURPOSE: The SPARED CRN (Study of Prostate Ablation Related Energy Devices Coordinated Registry Network) is a private-public partnership between academic and community urologists, the FDA (U.S. Food and Drug Administration), the Medical Device Epidemiology ...
Full textLink to itemCite
Journal ArticleWorld J Urol · October 2019
PURPOSE: To define the role of focal laser ablation (FLA) as clinical treatment of prostate cancer (PCa) using the Delphi consensus method. METHODS: A panel of international experts in the field of focal therapy (FT) in PCa conducted a collaborative consen ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · October 2019
PURPOSE: In order to better time salvage radiotherapy (SRT) for post-radical prostatectomy biochemical failure, we examined the association between pre-SRT prostate-specific antigen (PSA) and PSA control as a function of the new prognostic grade group (PGG ...
Full textLink to itemCite
Journal ArticleCan J Urol · October 2019
Prostate cancer screening remains controversial in the medical field. While screening men above 50 years can impose overdiagnosis and overtreatment, targeted screening of males with pathologic variants of genetic mutations is evolving and viewed as sensibl ...
Link to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · October 1, 2019
Prostate cancer diagnosis using standard transrectal ultrasound (TRUS) and systematic biopsy is challenging. To improve the performance of TRUS imaging, we combined it with acoustic radiation force impulse (ARFI) imaging and shear wave elasticity imaging ( ...
Full textCite
Journal ArticleJ Urol · September 2019
PURPOSE: Current trends in renal transplantation, such as improved allograft/recipient survival and expanded organ transplantation eligibility criteria in older recipients, are concomitant with increasingly detected low risk prostate cancer in candidates f ...
Full textLink to itemCite
Journal ArticleCancer · September 1, 2019
BACKGROUND: The current study was performed to evaluate the influence of race on the association between biopsy grade group (GrGp) and the risk of detectable prostate-specific antigen (PSA) and adverse histopathological outcomes after radical prostatectomy ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · August 2019
BACKGROUND: The purpose of the study was to examine the outcomes of salvage prostate cryoablation for managing patients with local recurrence after primary cryotherapy. PATIENTS AND METHODS: The records of 108 patients treated with salvage prostate cryoabl ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · April 2019
BACKGROUND/OBJECTIVES: Every year, up to 40% of the more than 16 million older Americans who undergo anesthesia/surgery develop postoperative cognitive dysfunction (POCD) or delirium. Each of these distinct syndromes is associated with decreased quality of ...
Full textOpen AccessLink to itemCite
Journal ArticleWorld J Urol · March 2019
INTRODUCTION: Long-term outcomes from large cohorts are not yet available upon which to base recommended follow-up protocols after prostate focal therapy. This is an updated summary of a 2015 SIU-ICUD review of the best available current evidence and exper ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · February 2019
PURPOSE: To investigate the preoperative use of combination metformin and statin versus monotherapy on biochemical recurrence (BCR) after radical prostatectomy (RP) in diabetic men. PATIENTS AND METHODS: Data of 843 diabetic men who underwent RP were strat ...
Full textLink to itemCite
Journal ArticleEur J Radiol · January 2019
PURPOSE: To introduce and assess the efficacy of a Reduced Core Targeted (RCT) biopsy template (image-targeted + laterally directed sextant biopsy) to detect clinically-significant cancer in patients with elevated PSA and a previous negative biopsy or on a ...
Full textLink to itemCite
Journal ArticleInt Braz J Urol · 2019
PURPOSE: To explore the potential association between renal mass characteristics and a history of chemotherapy. MATERIALS AND METHODS: A retrospective review of records of patients surgically treated for a localized renal mass between 2000 and 2012 was und ...
Full textLink to itemCite
Journal ArticleEur Urol · November 2018
The literature on focal therapy is currently insufficient to recommend it as first-line treatment. We need information from both randomised controlled trials and prospective registries for every available energy. That said, important research is under way ...
Full textLink to itemCite
Journal ArticleUrol Oncol · November 2018
PURPOSE: In response to controversy regarding prostate cancer (CaP) screening recommendations, a consolidated Duke Cancer Institute (DCI) multidisciplinary algorithm for CaP screening was developed and implemented. We conducted an online survey within the ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · November 2018
PURPOSE OF REVIEW: The current trend in image-based identification and characterization of prostate cancer (PCa) utilizing multiparametric MRI (mpMRI) has affected diagnostic and treatment planning in terms of targeted biopsy, risk stratification and progn ...
Full textLink to itemCite
Journal ArticleJ Urol · October 2018
PURPOSE: We assessed the predictive value of prostate specific antigen density to detect clinically significant prostate cancer, defined as prostate cancer grade group 2 or greater, in a series of men undergoing prostate biopsy with prostate specific antig ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · October 2018
BACKGROUND: African-American (AA) men have the greatest incidence of and disease-specific mortality from prostate cancer of any racial group. Although encouraging oncologic and functional outcomes have been reported with prostate cancer cryotherapy, little ...
Full textLink to itemCite
Journal ArticleJ Endourol · September 12, 2018
PURPOSE: To define the incidence and risk factors associated with rectourethral fistula (RUF) formation following primary whole-gland cryosurgery using a multicenter centralized registry. PATIENTS AND METHODS: The Cryo On-Line Data (COLD) registry was quer ...
Full textLink to itemCite
Journal ArticleUrol Oncol · August 2018
OBJECTIVE: To assess the associations between perioperative allogeneic blood transfusions (ABTs) and recurrence, overall and renal cell carcinoma (RCC)-specific survival in patients undergoing surgical treatment for clinically localized disease. MATERIALS ...
Full textLink to itemCite
Journal ArticleUrol Clin North Am · August 2018
Meaningful changes to the approach of prostate cancer staging and management have been made over the past decade with increasing demand for high-quality multiparametric MR imaging (mpMRI) of the prostate. This article focuses on the evolving paradigm of pr ...
Full textLink to itemCite
Journal ArticleJ Urol · June 2018
PURPOSE: The 4Kscore® test accurately detects aggressive prostate cancer and reduces unnecessary biopsies. However, its performance in African American men has been unknown. We assessed test performance in a cohort of men with a large African American repr ...
Full textLink to itemCite
Journal ArticleClin Genitourin Cancer · April 2018
INTRODUCTION: The purpose of this study was to assess the relationship of total prostate volume (TPV) and oncologic outcomes following focal prostate cryoablation. MATERIALS AND METHODS: A query of the Cryo On-Line Database (COLD) registry for men who unde ...
Full textLink to itemCite
Journal ArticleAbdom Radiol (NY) · March 2018
PURPOSE: Our objective is to determine the accuracy of multiparametric MRI (mpMRI) in predicting pathologic grade of prostate cancer (PCa) after radical prostatectomy (RP) using simple apparent diffusion coefficient metrics and, specifically, whether mpMRI ...
Full textLink to itemCite
Journal ArticleRadiol Clin North Am · March 2018
Meaningful changes to the approach of prostate cancer staging and management have been made over the past decade with increasing demand for high-quality multiparametric MR imaging (mpMRI) of the prostate. This article focuses on the evolving paradigm of pr ...
Full textLink to itemCite
Journal ArticleTher Adv Urol · January 2018
Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particularly in the primary care community. Our multidisciplinary prostate screening panel at Duke University Health System, USA created a nuanced PSA screening al ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · January 1, 2018
BACKGROUND: Diverse thermal ablative therapies are currently in use for the treatment of cancer. Commonly applied with the intent to cure, these ablative therapies are providing promising success rates similar to and often exceeding "gold standard" approac ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · January 1, 2018
This study demonstrates the implementation of a multiresolution shear wave tracking algorithm that enables elasticity imaging of prostate cancer and zonal anatomy. The combined ARFI/SWEI sequence uses closely-spaced push beams across the lateral field of v ...
Full textCite
ConferenceIEEE International Ultrasonics Symposium, IUS · January 1, 2018
Prostate lesions and healthy regions from 12 radical prostatectomy patients were identified in acoustic radiation force impulse (ARFI) imaging, shear wave elasticity imaging (SWEI), and multi-parametric magnetic resonance imaging (mpMRI) apparent diffusion ...
Full textCite
Journal ArticleCancer · November 1, 2017
BACKGROUND: A 5-tier prognostic grade group (GG) system was enacted to simplify the risk stratification of patients with prostate cancer in which Gleason scores of ≤6, 3 + 4, 4 + 3, 8, and 9 or 10 are considered GG 1 through 5, respectively. The authors in ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · September 2017
BACKGROUND: Whole-gland extirpation or irradiation is considered the gold standard for curative oncological treatment for localized prostate cancer, but is often associated with sexual and urinary impairment that adversely affects quality of life. This has ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · September 2017
BACKGROUND: Active surveillance (AS) has excellent short to medium term outcomes in well-selected prostate cancer patients. Traditional biopsy-based selection criteria have been criticized for inaccurate determination of cancer grade and extent. We evaluat ...
Full textLink to itemCite
Journal ArticleExpert Rev Anticancer Ther · August 2017
Prostate focal therapy offers men the opportunity to achieve oncological control while preserving sexual and urinary function. The prerequisites for successful focal therapy are to accurately identify, localize and completely ablate the clinically signific ...
Full textLink to itemCite
Journal ArticleUrol Oncol · July 2017
OBJECTIVES: To investigate the potential association between body mass index (BMI) and clinicopathological features of clinically localized renal masses. MATERIALS AND METHODS: An international, multi-institutional retrospective review of patients who unde ...
Full textLink to itemCite
Journal ArticleCurr Urol Rep · July 2017
PURPOSE OF REVIEW: Growing research supports the use of multiparametric magnetic resonance imaging (mpMRI) for the evaluation of localized prostate cancer (PCa). We highlight contemporary evidence supporting its use in active surveillance (AS). RECENT FIND ...
Full textLink to itemCite
Journal ArticleJ Endourol · June 2017
OBJECTIVE: To compare the oncologic and functional outcomes of partial vs whole-gland cryotherapy for men with intermediate-risk prostate cancer. SUBJECTS/PATIENTS: Men with intermediate-risk prostate cancer treated with primary prostate cryotherapy from 1 ...
Full textLink to itemCite
Journal ArticleWorld J Urol · May 2017
PURPOSE: To codify the use of multiparametric magnetic resonance imaging (mpMRI) for the interrogation of prostate neoplasia (PCa) in clinical practice and focal therapy (FT). METHODS: An international collaborative consensus project was undertaken using t ...
Full textLink to itemCite
Journal ArticleJ Endourol · May 2017
PURPOSE: To assess factors that affect prostate biopsy results following salvage whole gland cryoablation. PATIENTS AND METHODS: One hundred seventy-four patients underwent prostate biopsy following salvage whole gland cryoablation of the prostate in the C ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · March 2017
PURPOSE OF REVIEW: Progress in imaging, fusion software, and ablative modalities has fostered growth of the latest image-guided generation of high-intensity focused ultrasound (HIFU) for focal treatment of prostate cancer. Although early reports are encour ...
Full textLink to itemCite
Journal ArticleInt J Urol · February 2017
OBJECTIVE: To evaluate the diagnostic properties of multiparametric magnetic resonance imaging in the detection, localization and characterization of prostate cancer using three-dimensional transperineal template mapping biopsy histopathology as the compar ...
Full textLink to itemCite
Journal ArticleEur Urol · January 2017
CONTEXT: Focal therapy of prostate cancer has been proposed as an alternative to whole-gland treatments. OBJECTIVE: To summarize the evidence regarding sources of energy employed in focal therapy. EVIDENCE ACQUISITION: Embase and Medline (PubMed) were sear ...
Full textLink to itemCite
Chapter · January 1, 2017
Cryotherapy is a recognized treatment option for prostate cancer both in the primary and salvage settings. Herein, we summarize the current knowledge on cryotherapy for prostate cancer including elements of cryobiology, complications, oncological, and func ...
Full textCite
Journal ArticleFuture Oncol · November 2016
Prostate cancer is the most common noncutaneous cancer in men though many men will not die of this disease and may not require definitive treatment. Active surveillance (AS) is an increasingly utilized potential solution to the issue of overtreatment of pr ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · November 1, 2016
Current prostate cancer screening methods involve non-targeted needle biopsies and detection of clinically-insignificant lesions that receive excessive treatments, exposing patients to unnecessary adverse side effects and placing a burden on our health car ...
Full textCite
Journal ArticleWorld J Urol · October 2016
PURPOSE: To reach standardized terminology in focal therapy (FT) for prostate cancer (PCa). METHODS: A four-stage modified Delphi consensus project was undertaken among a panel of international experts in the field of FT for PCa. Data on terminology in FT ...
Full textLink to itemCite
Journal ArticleCurrent urology reports · October 2016
The goal of focal therapy is to achieve long-term oncological control by eradicating only the clinically significant focus/foci of cancer within the prostate, while preserving erectile function and continence. Anterior prostate cancers may have a PZ or TZ ...
Full textCite
Journal ArticleEur Urol · August 2016
UNLABELLED: Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in staging early prostate cancer (PCa) but remains heavily reader-dependent. We aim to define the incremental utility of mpMRI over clinical parameters in determining the p ...
Full textLink to itemCite
Journal ArticleInt J Urol · August 2016
OBJECTIVES: To study the effect of end-expiratory pressure used during anesthesia on blood loss during radical prostatectomy. METHODS: We evaluated 247 patients who underwent either radical retropubic prostatectomy or robot-assisted laparoscopic prostatect ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · July 2016
OBJECTIVE: The purpose of this study is to investigate the accuracy of multiparametric MRI with endorectal coil and Partin tables in predicting organ-confined (OC) prostate cancer in a contemporary cohort undergoing radical prostatectomy (RP) and to assess ...
Full textLink to itemCite
Journal ArticleArch Esp Urol · July 2016
OBJECTIVE: To systematically review the oncological and functional outcomes of contemporary primary prostate focal cryotherapy for localized prostate cancer in the context of current developments in prostate focal therapy. METHODS: We performed a systemati ...
Link to itemCite
Journal ArticleJ Endourol · June 2016
BACKGROUND AND OBJECTIVES: Salvage prostate cryoablation is an effective treatment for patients with localized prostate cancer relapse following primary radiotherapy. The postsalvage prostate-specific antigen (PSA) nadir that best predicts long-term bioche ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · June 2016
Overly aggressive prostate cancer (PCa) treatment adversely affects patients and places an unnecessary burden on our health care system. The inability to identify and grade clinically significant PCa lesions is a factor contributing to excessively aggressi ...
Full textLink to itemCite
Journal ArticleEur Urol · January 2016
CONTEXT: Cryoablation (CA) is a minimally invasive modality with low complication rates, but its use in urology is relatively recent. OBJECTIVE: To summarize available evidence for CA for small renal masses (SRMs) and to assess the selection criteria, comp ...
Full textLink to itemCite
Journal ArticleJ Endourol · January 2016
OBJECTIVE: To evaluate the oncological and functional outcomes of primary cryotherapy in men with clinically localized, high-grade prostate cancer. SUBJECTS AND METHODS: We included all men with biopsy Gleason score ≥8, localized (cT1-2) disease with a ser ...
Full textLink to itemCite
Journal ArticleExpert Rev Anticancer Ther · 2016
Multi-parametric MRI (mpMRI) is widely used in the detection and characterization of clinically- significant prostate cancer. MRI-TRUS (trans-rectal ultrasound) fusion biopsy is an in-office procedure that promises to empower urologists to successfully tar ...
Full textLink to itemCite
Journal ArticleJ Endourol · October 2015
BACKGROUND AND PURPOSE: The refinement in the localization of prostate cancer tumor foci through transperineal template-mapping biopsies and MRI has led to an increased interest in lesion-directed focal prostatic cryoablation. Data are lacking, however, th ...
Full textLink to itemCite
Journal ArticleWorld J Urol · October 2015
INTRODUCTION: Focal therapy can offer the middle ground for treatment between active surveillance and radical therapy in patients with low- and intermediate-risk prostate cancer. Factors that prohibit focal therapy from being standard of care are numerous. ...
Full textLink to itemCite
Journal ArticleProstate · September 2015
BACKGROUND: To create a predictive nomogram for biochemical failure following primary whole-gland cryoablation of the prostate for localized prostate cancer (LPCa). METHODS: We retrospectively analyzed 2,242 patients from the Cryo On-Line Database (COLD) w ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · August 2015
OBJECTIVE: The apparent diffusion coefficient (ADC) values for benign central zone (CZ) of the prostate were compared with ADC values of benign peripheral zone (PZ), benign transition zone (TZ), and prostate cancer, using histopathologic findings from radi ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · June 2015
It is now recognized that the tumor microenvironment creates a protective neo-tissue that isolates the tumor from the various defense strategies of the body. Evidence demonstrates that, with successive therapeutic attempts, cancer cells acquire resistance ...
Full textLink to itemCite
Journal ArticleCurr Urol Rep · June 2015
Prostate cancer (PCa) care is an ever-evolving field. Research and technological developments continue to refine our definitions and management of this disease. Now, with a greater understanding of the natural history of PCa, the prevention of overtreatmen ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · May 2015
PURPOSE OF REVIEW: In the absence of whole gland treatment for prostate cancer, both active surveillance and focal therapy share the common need of requiring a more thorough, detailed and precise analysis of the biological threats within the prostatic pare ...
Full textLink to itemCite
Journal ArticleEur Urol · April 2015
BACKGROUND: Focal therapy as a treatment option for localized prostate cancer (PCa) is an increasingly popular and rapidly evolving field. OBJECTIVE: To gather expert opinion on patient selection, interventions, and meaningful outcome measures for focal th ...
Full textLink to itemCite
Journal ArticleBiotech Histochem · April 2015
In vitro bioassay has been used extensively to test the effects of culturing cancer cells in sera from humans participating in dietary interventions, i.e, studies of modified intake of nutrients for the purpose of reducing cancer risk or progression. It ha ...
Full textLink to itemCite
Journal ArticleAbdom Imaging · January 2015
PURPOSE: To evaluate the impact of dedicated reader education on accuracy/confidence of peripheral zone index cancer and anterior prostate cancer (PCa) diagnosis with mpMRI; secondary aim was to assess the ability of readers to differentiate low-grade canc ...
Full textLink to itemCite
Journal ArticleUltrason Imaging · January 2015
Prostate cancer (PCa) is the most common non-cutaneous malignancy among men in the United States and the second leading cause of cancer-related death. Multi-parametric magnetic resonance imaging (mpMRI) has gained recent popularity to characterize PCa. Aco ...
Full textLink to itemCite
Chapter · January 1, 2015
Conventional B-mode transrectal ultrasound (TRUS) generates images of the acoustic properties of tissues (density and sound speed). TRUS is used extensively to aid in visualizing the prostate gland and needle during biopsy. However, TRUS has limited sensit ...
Full textCite
Chapter · January 1, 2015
Focal therapy is a treatment concept that is quite broad in clinical application, encompassing the spectrum of precise laser ablation of a tumor target to near complete destruction of a large portion of thegland, as long as sexual and urinary function can ...
Full textCite
Journal ArticleClin Cancer Res · December 15, 2014
PSA has led to a drastic increase in the detection of prostate cancer, rendering this biomarker the gateway for the diagnostic pathway of prostatic neoplasms. However, the increase in incidence has not been mirrored by a similar reduction in mortality. Wid ...
Full textLink to itemCite
Journal ArticleCurrent Radiology Reports · December 14, 2014
Multiparametric magnetic resonance imaging (mpMRI) of the prostate has become a mature and accepted technology in the evaluation of the patient with suspected prostate cancer (PCa). This review focuses on key recent developments in the area of mpMRI, speci ...
Full textCite
ConferenceIEEE International Ultrasonics Symposium, IUS · October 20, 2014
Imaging tools that reliably visualize prostate cancer (PCa) are increasingly needed in the urological community. The objective of this research was to evaluate the ability of Acoustic Radiation Force Impulse (ARFI) imaging to localize PCa in 29 patients wi ...
Full textCite
Journal ArticleOncol Nurs Forum · July 1, 2014
PURPOSE/OBJECTIVES: To describe the psychosocial trajectories of men treated surgically for prostate cancer after monitoring their prostate-specific antigen (PSA) levels until 24 months post-treatment. DESIGN: Descriptive longitudinal study. SETTING: Urolo ...
Full textLink to itemCite
Journal ArticleCurr Med Res Opin · May 2014
OBJECTIVE: To compare acute normovolemic hemodilution versus low central venous pressure strategy versus conventional fluid management in reducing intraoperative estimated blood loss, hematocrit drop and need for blood transfusion in patients undergoing ra ...
Full textLink to itemCite
Journal ArticleAnticancer Res · May 2014
BACKGROUND/AIM: In the cytokine era, cytoreductive nephrectomy (CN) improves survival for patients with metastatic renal cell carcinoma (mRCC). We analyzed the effect of CN on the survival of patients diagnosed with mRCC in the era of tyrosine kinase inhib ...
Link to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · December 1, 2013
Shear wave elasticity imaging (SWEI) has shown promise for visualizing structure and pathology within multiple organs; however, due to the assumptions of time of flight algorithms, artifacts caused by reflected waves at structural boundaries may be present ...
Full textCite
Journal ArticleJ Endourol · September 2013
BACKGROUND AND PURPOSE: Renal mass protocol CT (RMP-CT) using multiphase abdomen and pelvis CT imaging is the mainstay for diagnosis, characterization, and follow-up for renal masses; however, it is associated with ionizing radiation to the patient. We sou ...
Full textLink to itemCite
Journal ArticleBJU Int · August 2013
OBJECTIVE: To evaluate side-effects, erectile function and capability to preserve adjacent tissues of bilateral focal prostate ablation using low-energy direct current (LEDC) in a canine model. MATERIALS AND METHODS: In all, 12 male Beagle dogs underwent b ...
Full textLink to itemCite
Journal ArticleJ Med Food · April 2013
Enterolactone and enterodiol, mammalian lignans derived from dietary sources such as flaxseed, sesame seeds, kale, broccoli, and apricots, may impede tumor proliferation by inhibiting activation of nuclear factor kappa B (NFκB) and vascular endothelial gro ...
Full textLink to itemCite
Journal ArticleOncology (Williston Park) · April 2013
Compared with earlier prostate MRI techniques that suffered from relatively poor sensitivity and specificity for detecting prostate cancer because of their reliance predominantly on morphology, multiparametric prostate MRI (mpMRI) in 2013 provides a wealth ...
Link to itemCite
Journal ArticleMed Oncol · March 2013
To assess preoperative parameters that may be predictive of pathologic stage T2a (pT2a) and pathologic Gleason score (pGS) ≤ 6 disease in low-risk prostate cancer patients considering active surveillance. A cohort of 1,495 men with low-risk prostate cancer ...
Full textLink to itemCite
Journal ArticleAndrology · March 2013
Changes in sexual bother (SB) following radical prostatectomy (RP) negatively affect health-related quality of life (HRQoL) of prostate cancer survivors. However, post-operative SB tends to be neglected whereas sexual function (SF) is thoroughly assessed i ...
Full textLink to itemCite
Journal ArticleOncology (Williston Park) · January 2013
The landscape of prostate cancer has been rapidly evolving, and technological advances in imaging and biopsy tools offer novel approaches to focal therapy. In this dynamic environment, the role of focal therapy for prostate cancer is being shaped both by a ...
Link to itemCite
Journal ArticleOncology (Williston Park, N.Y.) · January 1, 2013
The landscape of prostate cancer has been rapidly evolving, and technological advances in imaging and biopsy tools offer novel approaches to focal therapy. In this dynamic environment, the role of focal therapy for prostate cancer is being shaped both by a ...
Cite
ConferenceIEEE International Ultrasonics Symposium, IUS · December 1, 2012
In the prostate, ARFI and SWEI imaging methods have reported that cancer and other pathologies as being stiffer than the surrounding tissue. A three-dimensional in vivo prostatic imaging system capable of concurrently acquiring ARFI and SWEI data was devel ...
Full textCite
Journal ArticleJ Endourol · November 2012
BACKGROUND AND PURPOSE: In this study, we investigated the potential of a new class of therapeutic Mn porphyrins as molecular MRI probes for prostate cancer imaging. Two compounds of different bioavailibility were investigated: Mn(III) meso-tetrakis(N-ethy ...
Full textLink to itemCite
Journal ArticleJ Endourol · October 2012
BACKGROUND AND PURPOSE: Surgical management of a renal neoplasm in a solitary kidney is a balance between oncologic control and preservation of renal function. We analyzed patients with a renal mass in a solitary kidney undergoing nephron-sparing procedure ...
Full textLink to itemCite
Journal ArticleBJU Int · October 2012
What's known on the subject? and What does the study add? Focal therapy techniques are emerging in prostate cancer treatment. However, several key questions about patient selection, treatment and monitoring still have to be addressed. The concept of focal ...
Full textLink to itemCite
Journal ArticleEur Urol · September 2012
CONTEXT: The use of percutaneous biopsy of renal tumours has been traditionally reserved for selected cases because of uncertainties regarding its safety, accuracy, and clinical utility. With the adoption of modern biopsy techniques and increasing expertis ...
Full textLink to itemCite
Journal ArticleUrology · July 2012
OBJECTIVE: To compare the characteristics and predictors of cancer-specific survival (CSS) of 2 rare distal nephron tumors--medullary renal cell carcinoma (MRCC) and collecting duct carcinoma (CDC). METHODS: All cases of histologically verified MRCC and CD ...
Full textLink to itemCite
Journal ArticleBJU Int · June 2012
Featured Publication
UNLABELLED: What's known on the subject? and What does the study add? Active surveillance for prostate cancer is gaining increasing acceptance for low risk prostate cancer. Focal therapy is an emerging tissue preservation strategy that aims for treat only ...
Full textLink to itemCite
Journal ArticleJ Sex Med · June 2012
INTRODUCTION: Chronic oxidative stress is one of the major factors playing an important role in radiation-induced normal tissue injury. However, the role of oxidative stress in radiation-induced erectile dysfunction (ED) has not been fully investigated. Ai ...
Full textLink to itemCite
Journal ArticleJ Endourol · April 2012
Featured Publication
BACKGROUND AND PURPOSE: Renal cryoablation has gained popularity as a treatment option for localized renal masses. Treatment success is typically defined by the absence of contrast enhancement on follow-up imaging. We investigate the evolution of lesions t ...
Full textLink to itemCite
Journal ArticleCurr Urol Rep · April 2012
Featured Publication
Focal therapy for prostate cancer has been increasingly utilized with the goal of effective disease control while maximizing patient functional outcomes. The optimal patient selection criteria are not known and therefore are not standardized. This review c ...
Full textLink to itemCite
Journal ArticleJ Sex Med · April 2012
Featured Publication
INTRODUCTION: Erectile dysfunction (ED) is related to several co-morbidities including obesity, metabolic syndrome, cigarette smoking, and low testosterone, all of which have been reported to be associated with adverse prostate cancer features. AIM: To exa ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · April 1, 2012
Featured Publication
PURPOSE: To determine whether an increasing number of high-risk factors is associated with higher prostate cancer-specific mortality (PCSM) among men treated with brachytherapy (BT)-based treatment, and whether supplemental therapy has an impact on this ri ...
Full textLink to itemCite
Journal ArticleBJU Int · March 2012
Featured Publication
OBJECTIVES: There has been a call in the urological literature for standardized reporting of complications. To use strict criteria aiming to report our complications and other postoperative events in a cohort of men undergoing third-generation prostate cry ...
Full textLink to itemCite
Journal ArticleBJU Int · March 2012
Featured Publication
OBJECTIVES: To investigate the effect and molecular mechanisms of action of Vitamin D(3) (VD(3) ) as a neo-adjunctive agent before cryosurgery in an effort to increase treatment efficacy for prostate cancer (CaP). To eliminate the potential for disease rec ...
Full textLink to itemCite
Chapter · January 5, 2012
Cryosurgery represents a recognized option for the treatment of prostate cancer. Herein we discuss the principles of cryobiology and their implications in modern cryosurgery, review the indications for primary and salvage cryotherapy, as well as summarize ...
Full textCite
Chapter · January 1, 2012
Cryotherapy is a recognized treatment option for prostate cancer both in the primary and salvage settings. Herein, we summarize the current knowledge on cryotherapy for prostate cancer including elements of cryobiology, complications, and oncological outco ...
Full textCite
Journal ArticleUrol Oncol · 2012
Featured Publication
OBJECTIVES: Prostate cancer (CaP) cryosurgery utilizes PSA nadir level and radiotherapy criteria as surrogates for success. We attempted to correlate PSA doubling time (PSAdt) and time of undetectable PSA (TUPSA) with biopsy-proven cancer recurrence (BPR) ...
Full textLink to itemCite
Journal ArticleUrol Oncol · 2012
Featured Publication
OBJECTIVE: To evaluate the association between prostate weight and the diagnostic performance of routine biopsy schemes in detecting unilateral prostate cancer (PCa) that may be amenable to focal therapy. METHODS AND MATERIALS: Retrospective analysis of pa ...
Full textLink to itemCite
Journal ArticleUrol Oncol · 2012
Featured Publication
OBJECTIVES: In this study, we evaluate the diagnostic utility of a hybrid γ-camera-computer tomography (SPECT-CT) indium-111 (111-In)-capromab pendetide scan in detecting seminal vesicle invasion (SVI) in select patients evaluated for primary surgical trea ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · January 2012
Featured Publication
Reliably detecting prostate cancer (PCa) has been a challenge for current imaging modalities. Acoustic radiation force impulse (ARFI) imaging is an elasticity imaging method that uses remotely generated, focused acoustic beams to probe tissue stiffness. A ...
Full textLink to itemCite
Journal ArticleUrology · January 2012
Featured Publication
OBJECTIVE: To assess the effect of noise-cancelling headphones with or without music on patient pain and anxiety associated with routine, office-based transrectal ultrasound (TRUS)-guided prostate biopsy in a prospective randomized study. METHODS: Patients ...
Full textLink to itemCite
Journal ArticleJ Urol · January 2012
Featured Publication
PURPOSE: The multidisciplinary approach is becoming increasingly encouraged but little is known about the multidisciplinary experience compared to routine care. For patients with prostate cancer the goal is to provide evaluations by urologists, medical and ...
Full textLink to itemCite
Journal ArticleUrol Int · 2012
OBJECTIVE: To assess preoperative parameters that may be predictive of pathologic stage T2a disease in low-risk prostate cancer patients. METHODS: Data from a cohort of 1,495 consecutive men with low-risk prostate cancer who underwent a radical prostatecto ...
Full textLink to itemCite
Journal ArticlePLoS One · 2012
Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have ...
Full textOpen AccessLink to itemCite
ConferenceIEEE International Ultrasonics Symposium, IUS · December 1, 2011
Acoustic Radiation Force Impulse (ARFI) imaging is being developed for guiding needle biopsy and focal therapy of Prostate cancer (PCa). In vivo ARFI images portray internal structures in the prostate with higher contrast than matched B-mode images. Given ...
Full textCite
Journal ArticleJ Endourol · November 3, 2011
Featured Publication
BACKGROUND AND PURPOSE: In this study, we investigated the potential of a new class of therapeutic Mn porphyrins as molecular MRI probes for prostate cancer imaging. Two compounds of different bioavailibility were investigated: Mn(III) meso-tetrakis(N-ethy ...
Full textLink to itemCite
Journal ArticleEur Urol · October 2011
Featured Publication
CONTEXT: The increasing incidence of localised renal cell carcinoma (RCC) over the last 3 decades and controversy over mortality rates have prompted reassessment of current treatment. OBJECTIVE: To critically review the recent data on the management of loc ...
Full textLink to itemCite
Journal ArticleBJU Int · October 2011
Featured Publication
OBJECTIVE: • To better understand the biology and incidence of the cancer foci within the prostate through a comprehensive literature review and a review of our own data, to establish the current level of knowledge regarding the pathological foundation for ...
Full textLink to itemCite
Journal ArticleCancer Prev Res (Phila) · October 2011
Featured Publication
Diet, nutritional status, and certain dietary supplements are postulated to influence the development and progression of prostate cancer. Angiogenesis and inflammation are central to tumor growth and progression, but the effect of diet on these processes r ...
Full textLink to itemCite
Journal ArticleJ Sex Med · October 2011
Featured Publication
INTRODUCTION: The association between early and late phase sexual health-related quality of life (HRQoL) following radical prostatectomy (RP) is unclear. Moreover, factors that predict either early or late sexual HRQoL decline have not been fully investiga ...
Full textLink to itemCite
Journal ArticleCancer · September 1, 2011
Featured Publication
BACKGROUND: A survival benefit has been observed with salvage radiation therapy (RT) for prostate-specific antigen (PSA) failure after radical prostatectomy (RP) in men with rapid rises in PSA doubling time (DT, < 6 months). Whether such a benefit exits in ...
Full textLink to itemCite
Journal ArticleJ Endourol · August 2011
Featured Publication
BACKGROUND AND PURPOSE: Laparoscopic cryoablation (LCA) has emerged as an alternative to conventional surgery for the management of a T(1) renal mass; however, only few data are available on its functional outcomes. We assessed renal function changes after ...
Full textLink to itemCite
Journal ArticleJ Sex Med · August 2011
Featured Publication
INTRODUCTION: The mechanisms of radiation-induced erectile dysfunction (ED) are unclear, as clinical studies are limited, and previous animal models were based on wide-field irradiation, which does not model current radiotherapy (RT) techniques. AIMS: To p ...
Full textLink to itemCite
Journal ArticleBJU Int · July 2011
Featured Publication
OBJECTIVE: • To evaluate weather prostate-specific antigen (PSA) velocity could be used to stratify patients at risk of death from prostate cancer (PCa) and be useful in aiding decision making regarding PSA screening in elderly men, as previous studies hav ...
Full textLink to itemCite
OtherInternational Braz J Urol · July 1, 2011
Background and Purpose: Laparoscopic cryoablation (LCA) has emerged as an alternative to conventional surgery for the management of a T(1) renal mass; however, only few data are available on its functional outcomes. We assessed renal function changes after ...
Full textCite
Journal ArticleProstate Cancer Prostatic Dis · June 2011
Featured Publication
Cryotherapy has emerged as a primary treatment option for prostate cancer (CaP); however, incomplete ablation in the periphery of the cryogenic lesion can lead to recurrence. Accordingly, we investigated the use of a non-toxic adjunctive agent, vitamin D3 ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2011
Featured Publication
PURPOSE: Cigarette smoking is a recognized risk factor for renal cell carcinoma (RCC), but little data are available on the association between smoking and RCC biology. We investigated the association between cigarette smoking and RCC stage in a large cont ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · April 2011
Featured Publication
OBJECTIVE: The purpose of this study was to determine the incidence of collecting system and hemorrhagic complications resulting from CT-guided percutaneous cryoablation of renal tumors in which the radiographic ice ball abuts or involves the renal sinus. ...
Full textLink to itemCite
Journal ArticleBJU Int · March 2011
Featured Publication
OBJECTIVE: • To evaluate the influence of radiographic tumour size and other preoperative variables on the pathological characteristics of the lesion to determine the distribution of pathological features and assess preoperative risk factors for potentiall ...
Full textLink to itemCite
Journal ArticleUrol Oncol · 2011
Featured Publication
We evaluate the reliability of routine sextant prostate biopsy to detect unilateral lesions. A total of 365 men with complete records including all clinical and pathologic variables who underwent a preoperative sextant biopsy and subsequent radical prostat ...
Full textLink to itemCite
Journal ArticleInt J Impot Res · 2011
Featured Publication
Prostate cryoablation is an established minimally invasive treatment for localized prostate cancer (PCa). However, the impairment of erectile function (EF) is considered a serious complication of the procedure. To investigate the efficacy of erectile aids ...
Full textLink to itemCite
Journal ArticleBJU Int · December 2010
Featured Publication
OBJECTIVE: To determine the adequacy of T2 prostate cancer (PCa) sub-staging as an independent Predictor of biochemical disease-free survival (bDFS) after radical prostatectomy. MATERIALS AND METHODS: The Duke Prostate Center database was queried for patie ...
Full textLink to itemCite
Journal ArticleBJU Int · December 2010
Featured Publication
OBJECTIVE: To investigate whether salvage radiation therapy (RT) for prostate-specific antigen (PSA) failure can provide the same result as adjuvant RT, which decreases the risk of all-cause mortality (ACM) for men with positive margins (R1), or extra-caps ...
Full textLink to itemCite
Journal ArticleUrology · November 2010
Featured Publication
OBJECTIVES: To evaluate changes in urinary function after cryoablation for clinically localized prostate cancer and to investigate risk factors that predict changes in urinary function after surgery. METHODS: Among the patients who underwent primary or sal ...
Full textLink to itemCite
Journal ArticleUrology · November 2010
Featured Publication
OBJECTIVES: To evaluate the relationship between initial prostate-specific antigen (PSA) and prostate cancer (PCa) risk in elderly African American (AA) and Caucasian American (CA) men. METHODS: A total of 408 AA and 1720 CA men whose initial PSA measureme ...
Full textLink to itemCite
Journal ArticleCancer · October 15, 2010
Featured Publication
BACKGROUND: A diagnosis of prostate cancer is not often predictive of death from prostate cancer because of competing causes of mortality. Identification of the risk of death from prostate cancer and death from all causes using information available at the ...
Full textLink to itemCite
Journal ArticleBJU Int · October 2010
Featured Publication
OBJECTIVE: to analyse the relationship between African American (AA) race and obesity in men with prostate cancer. PATIENTS AND METHODS: in all, 4196 patients who underwent radical prostatectomy from 1988 to 2008 were identified in the Duke Prostate Center ...
Full textLink to itemCite
Journal ArticleUltrason Imaging · October 2010
Featured Publication
Acoustic Radiation Force Impulse (ARFI) imaging has been previously reported to portray normal anatomic structures and pathologies in ex vivo human prostates with good contrast and resolution. These findings were based on comparison with histological slide ...
Full textLink to itemCite
Journal ArticleUrology · September 2010
Featured Publication
OBJECTIVES: Calcitriol has been reported to have antitumor efficacy in several cancers. In this study, we hypothesized that calcitriol may potentially function as a cryosensitizer that can enhance cryoablation, and we investigated several molecular marker ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · September 2010
Featured Publication
The objective of this study was to preoperatively predict non-organ-confined disease in patients considering radical prostatectomy. To account for the stage migration seen in prostate cancer, we included only those patients who underwent prostatectomy afte ...
Full textLink to itemCite
Journal ArticleCryobiology · August 2010
Featured Publication
The aim of this study is to investigate the tumor tissue changes in terms of hypoxia and demonstrate its relationship to vascularity and apoptosis following therapeutic cryoablation in a prostate tumor murine model. Total 67 male C57BL/J6 mice were assigne ...
Full textLink to itemCite
Journal ArticleEur Urol · July 2010
Featured Publication
BACKGROUND: Laparoscopic cryoablation (LCA) and percutaneous cryoablation (PCA) of small renal masses have gained popularity, but only limited data exist on the complication rates. OBJECTIVES: In this study, we report on postoperative complications associa ...
Full textLink to itemCite
Journal ArticleEur Urol · July 2010
Featured Publication
CONTEXT: A significant proportion of patients diagnosed with prostate cancer have well-differentiated, low-volume tumors at minimal risk of impacting their quality of life or longevity. The selection of a treatment strategy, among the multitude of options, ...
Full textLink to itemCite
Journal ArticleEur Urol · July 2010
Featured Publication
BACKGROUND: Multifocal renal cell carcinoma (RCC) has been reported in up to 25% of all radical nephrectomy specimens. Modern imaging tends to underestimate the rate of multifocality. Recognition of multifocality before treatment may guide physicians and p ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · June 2010
Featured Publication
Cryoablation has emerged as a primary therapy to treat prostate cancer. Although effective, the assumption that freezing serves as a ubiquitous lethal stress is challenged by clinical experience and experimental evidence demonstrating time-temperature-rela ...
Full textLink to itemCite
Journal ArticleJ Endourol · May 2010
Featured Publication
Focal therapy (FT) for the management of clinically localized prostate cancer (PCa) is growing from a concept to reality because of increased interest of both patients and physicians. Selection protocols, however, are yet to be established. We discuss the ...
Full textOpen AccessLink to itemCite
Journal ArticleCurr Urol Rep · May 2010
Featured Publication
Focal therapy for prostate cancer has emerged an interesting concept as a less morbid option for the treatment of localized low-risk disease. Despite the growing interest in focal therapy, this approach has not yet gained sufficient popularity nor provided ...
Full textLink to itemCite
Journal ArticleJ Endourol · May 2010
Featured Publication
The concept of focal therapy is rapidly evolving and gaining popularity from both physician and patient perspectives. We review the rationale, candidate selection, and results of the first clinical studies of focal cryoablation for selected patients with l ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Endourol · May 2010
Featured Publication
Since at least the early 1990s, stage and risk migration have been seen in patients with prostate cancer, likely corresponding to the institution of prostate specific antigen (PSA) screening in health systems. Preoperative risk factors, including PSA level ...
Full textOpen AccessLink to itemCite
Journal ArticleUrology · May 2010
Featured Publication
OBJECTIVES: To evaluate the US Preventative Services Task Force (USPSTF) recommendation to discontinue prostate-specific antigen (PSA) screening at age 75. METHODS: Public survey: A cohort of 340 patients was surveyed at our PSA screening clinic and strati ...
Full textLink to itemCite
Journal ArticleJ Endourol · May 2010
PURPOSE: To establish a consensus in relation to case selection, conduct of therapy, and outcomes that are associated with focal therapy for men with localized prostate cancer. MATERIAL AND METHODS: Urologic surgeons, radiation oncologists, radiologists, a ...
Full textOpen AccessLink to itemCite
Journal ArticleCancer · April 15, 2010
Featured Publication
BACKGROUND: This report evaluated whether biochemical recurrence (BCR) as a time-dependent covariate (t) after radical prostatectomy (RP) for prostate cancer was associated with the risk of death and whether salvage therapy with radiotherapy (RT) and/or ho ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · April 2010
Featured Publication
It has been challenging for clinicians using current imaging modalities to visualize internal structures and detect lesions inside human prostates. Lack of contrast among prostatic tissues and high false positive or negative detection rates of prostate les ...
Full textLink to itemCite
Journal ArticleBJU Int · April 2010
Featured Publication
OBJECTIVE: To compare the diagnostic properties of routine office-based sextant and extended biopsies for unilateral prostate cancer, as validated by final pathology, because focal therapy of prostate cancer is gaining acceptance as a viable treatment opti ...
Full textLink to itemCite
Journal ArticleInt J Urol · March 2010
Featured Publication
Due to a number of evolving devices and modalities to treat the small, localized renal mass, the physician and patient have the opportunity to choose an appropriate therapy from several treatment options. Minimally invasive surgery to ablate a localized re ...
Full textLink to itemCite
Journal ArticleJ Urol · March 2010
Featured Publication
PURPOSE: Studies show that initial prostate specific antigen higher than the median in young men predicts a subsequent higher risk of prostate cancer. To our knowledge this relationship has not been studied in patients stratified by race. MATERIALS AND MET ...
Full textLink to itemCite
Journal ArticleJ Urol · March 2010
Featured Publication
PURPOSE: We determined the predictive power of tumor percent involvement on prostate specific antigen recurrence in patients when stratified by prostate weight. MATERIALS AND METHODS: Data on 3,057 patients who underwent radical prostatectomy between 1988 ...
Full textLink to itemCite
Journal ArticleUrology · February 2010
Featured Publication
OBJECTIVE: To analyze factors that may contribute to local relapse after laparoscopic cryoablation (LCA) of renal tumors. LCA has gained popularity in the treatment of small renal tumors, but local tumor control remains a concern. METHODS: We analyzed 163 ...
Full textLink to itemCite
Journal ArticleUrology · February 2010
Featured Publication
OBJECTIVES: To compare the effects of tumor volume (TV), tumor percentage involvement (TPI), and prostate volume (PV) on prostate-specific antigen (PSA) recurrence (PSAR) after radical prostatectomy (RP). METHODS: A cohort of 3528 patients receiving RP bet ...
Full textLink to itemCite
Journal ArticleF1000 Med Rep · January 18, 2010
Featured Publication
The concept of focal therapy in oncologic surgery refers to maximizing healthy tissue preservation while maintaining excellent cancer control outcomes. Herein, we address the recent advantages in the field of focal therapy for both kidney and prostate canc ...
Full textLink to itemCite
Journal ArticleBJU Int · January 2010
Featured Publication
We reviewed the current salvage methods for patients with local recurrent prostate cancer after primary radiotherapy (RT), using a search of relevant Medline/PubMed articles published from 1982 to 2008, with the following search terms: 'radiorecurrent pros ...
Full textLink to itemCite
Journal ArticleInt J Urol · December 2009
Featured Publication
The aim of this study was to evaluate the diagnostic value of a hybrid (111)In-capromab pendetide fused computed tomography (CT) scan in detecting seminal vesicle invasion (SVI) in the setting of recurrent prostate cancer following primary in situ therapy. ...
Full textLink to itemCite
Journal ArticleUrology · November 2009
Featured Publication
OBJECTIVES: To compare Gleason scores (GS) originally assigned in the mid 1990s with the current pathologic evaluation of the same prostatectomy slides, and to assess the GS migration effect on outcome in patients undergoing surgical treatment of prostate ...
Full textLink to itemCite
Journal ArticleJ Urol · November 2009
Featured Publication
PURPOSE: We clarified whether men older than 70 years have a higher risk of prostate cancer and poorer survival in the early and late prostate specific antigen eras. MATERIALS AND METHODS: A cohort of 4,561 men who underwent radical prostatectomy were stra ...
Full textLink to itemCite
Journal ArticleDrug Des Devel Ther · September 21, 2009
Featured Publication
Bone metastases frequently occur in patients with advanced solid tumors, particularly breast and prostate cancers, and nearly all patients with multiple myeloma have some degree of skeletal involvement. The strides made in treating these primary tumors hav ...
Link to itemCite
Journal ArticleJ Urol · September 2009
Featured Publication
PURPOSE: We compared the results of a preoperative (111)In-capromab pendetide scan co-registered with computerized tomography with pathological findings in the surgically excised prostate to determine whether the scan can efficiently detect cancer in the p ...
Full textLink to itemCite
Journal ArticleUrology · September 2009
Featured Publication
OBJECTIVES: To identify factors that predict delayed (> 5 years) prostate-specific antigen recurrence (PSAR) after radical prostatectomy (RP) and to analyze the associated clinical outcomes. METHODS: A cohort of 4561 men who underwent RP between 1988 and 2 ...
Full textLink to itemCite
Journal ArticleUrology · September 2009
OBJECTIVES: To clarify the relationship between age and pathologic Gleason score and their effect on prostate-specific antigen recurrence (PSAR). METHODS: The data from a cohort of 2911 men who had undergone radical prostatectomy from 1988 to 2006 were ret ...
Full textLink to itemCite
Journal ArticleJ Clin Anesth · August 2009
Featured Publication
STUDY OBJECTIVE: To compare anesthetic management and postoperative outcomes in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP) and radical retropubic prostatectomy (RRP) with general anesthesia. DESIGN: Retrospective database ...
Full textLink to itemCite
Journal ArticleJ Urol · July 2009
Featured Publication
PURPOSE: We determined clinical factors affecting the under grading of biopsy Gleason sum compared with prostatectomy pathology and developed a model predicting the probability of under grading. MATERIALS AND METHODS: We analyzed a cohort of 1,701 patients ...
Full textLink to itemCite
Journal ArticleAnesth Analg · June 2009
Featured Publication
In a prospective, double-blind, placebo-controlled study, patients undergoing radical retropubic prostatectomy under general anesthesia were randomly assigned to receive a lidocaine patch or placebo applied on each side of the wound at the end of surgery. ...
Full textLink to itemCite
Journal ArticleCancer · May 15, 2009
Featured Publication
BACKGROUND: The application of focal therapy for low-risk prostate cancer (PCa) depended on appropriate patient selection. No definitive criteria existed to characterize patients who may potentially benefit from an organ-sparing approach. We evaluated pret ...
Full textLink to itemCite
Journal ArticleNat Rev Urol · April 2009
Featured Publication
The treatment paradigm for small-volume, low-grade unifocal or unilateral prostate cancer is shifting from a radical, whole-gland approach toward organ-sparing, focal ablation. The widely implemented screening program in the US has detected small-volume pr ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · April 2009
Featured Publication
The 3-D transrectal ultrasound (TRUS)-guided prostate biopsy system is a novel device that allows precise needle placement in a template fashion. We evaluate its utility for prostate cancer (PCa) detection. A retrospective analysis was performed evaluating ...
Full textLink to itemCite
Journal ArticleEuropean Urology, Supplements · April 1, 2009
Context: Focal targeted therapy of early stage prostate cancer (PCa) can ideally facilitate the concept of personalized medicine in contemporary surgical oncology. Objective: To present indications and outcomes of subtotal glandular ablation. This treatmen ...
Full textCite
Journal ArticleCurr Opin Urol · March 2009
Featured Publication
PURPOSE OF REVIEW: This review highlights current features of the changing landscape of the US population with newly diagnosed prostate cancer and discusses new treatment options utilizing noninvasive or minimally invasive management. RECENT FINDINGS: Rece ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · March 2009
Featured Publication
PURPOSE OF REVIEW: We evaluate the rationale, candidate selection, and results of the first clinical studies of focal cryoablation for select patients with low volume and low-to-low - moderate risk features of prostate cancer as a possible alternative to w ...
Full textLink to itemCite
Journal ArticleInt Braz J Urol · 2009
Featured Publication
PURPOSE: Both the diagnosis of prostate cancer (PCa) and the physiologic outcomes of surgical treatment impact the male's psychological sphere. However, current research advocates a refocusing of outcomes directed to the PCa "couple". Herein we acquire ins ...
Full textLink to itemCite
Journal ArticleInt J Impot Res · 2009
Featured Publication
Although prostate cancer affects men, research shows effects on both members of the couple. We analyzed concordance in couples recovering from primary surgical treatment of prostate cancer when surveyed on psychological domains including emotional status, ...
Full textLink to itemCite
ConferenceProceedings - IEEE Ultrasonics Symposium · January 1, 2009
Acoustic Radiation Force Impulse (ARFI) imaging has previously been used to visualize normal anatomic structures and pathologies in both ex vivo and in vivo human prostates. Based on the relative displacement amplitudes in ARFI images and comparison with h ...
Full textCite
Journal ArticleCancer Epidemiol Biomarkers Prev · December 2008
Featured Publication
BACKGROUND: Prostate cancer affects one of six men during their lifetime. Dietary factors are postulated to influence the development and progression of prostate cancer. Low-fat diets and flaxseed supplementation may offer potentially protective strategies ...
Full textLink to itemCite
Journal ArticleCancer · November 15, 2008
Featured Publication
BACKGROUND: Both the 5-item short version of the International Index of Erectile Function (IIEF-5) and the Expanded Prostate Cancer Index Composite (EPIC) have been used to assess erectile function. In this study, the authors compared various definitions o ...
Full textLink to itemCite
Journal ArticleJ Endourol · November 2008
Featured Publication
PURPOSE: We evaluated the clinical implication of persistent contrast enhancement demonstrated several months after laparoscopic renal cryoablation of a small renal mass. PATIENTS AND METHODS: Between September 2000 and May 2007, 30 patients underwent lapa ...
Full textLink to itemCite
Journal ArticleUrology · October 2008
Featured Publication
OBJECTIVES: To assess the discrepancies between diagnostic and pathologic Gleason sums and the predictive role of age and prostate-specific antigen (PSA) level on Gleason sum discrepancies. METHODS: A total of 2963 patients receiving radical prostatectomy ...
Full textLink to itemCite
Journal ArticleProstate · September 15, 2008
Featured Publication
BACKGROUND: Early detection of small volume prostate cancer (PCa) has led to the concept of focal therapy to treat in an organ-sparing manner. We evaluated trends in pathologic staging among patients with localized PCa undergoing radical prostatectomy (RP) ...
Full textLink to itemCite
Journal ArticleUrology · September 2008
Featured Publication
Laparoscopic cryoablation is a minimally invasive treatment that is currently used to treat small renal tumors. Despite its growing use and promising outcomes, complications can occur. We report the first clinical case of urothelial sloughing with obstruct ...
Full textLink to itemCite
Journal ArticleAnesth Analg · September 2008
Featured Publication
BACKGROUND: Previous animal and human studies suggested that nicotine might have an antinociceptive effect. We hypothesized that the preoperative application of a 7 mg nicotine patch would result in reduced postoperative analgesic requirements in patients ...
Full textLink to itemCite
Journal ArticleBJU Int · August 5, 2008
Featured Publication
OBJECTIVE: To explore the ability of a novel transrectal ultrasonography (TRUS) device (TargetScan, Envisioneering Medical Technologies, St. Louis MO) that creates a three-dimensional map of the prostate and calculates an optimal biopsy scheme, to accurate ...
Full textLink to itemCite
Journal ArticleCan J Urol · August 2008
Featured Publication
INTRODUCTION: Given the improved therapeutic efficacy and acceptable side effect profile with current cryotechnology, we wish to better understand the attitudes of community urologists expressing interest in this treatment modality toward the adoption of c ...
Link to itemCite
Journal ArticleJ Endourol · August 2008
Featured Publication
BACKGROUND AND PURPOSE: We evaluated the effects of the first freeze-thaw cycle of cryoablation on Fuhrman grade, histology, and tumor architecture of small clear cell renal carcinomas and renal oncocytomas using an 18-gauge needle biopsy. PATIENTS AND MET ...
Full textLink to itemCite
Journal ArticleOncology (Williston Park) · July 2008
Featured Publication
The intermediate and long-term results of primary full-gland cryoablation for localized prostate cancer with moderate- and high-risk patients suggests a cancer control rate similar to what can be achieved with radiotherapy and surgery, with an acceptable r ...
Link to itemCite
Journal ArticleBJU Int · July 2008
Featured Publication
OBJECTIVES: To compare the prostate-specific antigen (PSA) recurrence (PSAR) rates in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP) or radical retropubic prostatectomy (RRP). PATIENTS AND METHODS: Data from 797 consecutive pa ...
Full textLink to itemCite
Journal ArticleUrology · June 2008
Featured Publication
OBJECTIVES: We evaluated the lower threshold of prostate-specific antigen (PSA) and prostate-specific antigen velocity (PSAV) in a population of men over 70 years of age. METHODS: Between January 1988 and December 2005, 4038 men over 70 years of age includ ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · June 1, 2008
Featured Publication
PURPOSE: The (111)In-capromab pendetide scan (ProstaScint; Cytogen Corp., Princeton NJ) is approved by the Food and Drug Administration to evaluate increasing prostate-specific antigen (PSA) levels after radical prostatectomy. This study evaluated the role ...
Full textLink to itemCite
OtherProstate Cancer Prostatic Dis · May 13, 2008
Featured Publication
The authors hereby retract the e-publication dated 13 May 2008 and entitled, 'Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?' The authors are submitting a revised version w ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · May 2008
Featured Publication
PURPOSE OF REVIEW: Nowadays the treatment paradigm for localized prostate cancer is to distinguish patients with clinically relevant cancers who may benefit from radical treatment, or perhaps an organ-sparing approach, from the remainder who may not need i ...
Full textLink to itemCite
Journal ArticleTher Clin Risk Manag · February 2008
Featured Publication
Many patients with advanced cancer experience decreased bone strength due to metastatic foci, underlying osteoporosis and/or cancer treatment induced bone loss. The clinical consequences of metastatic disease involving the skeleton are widespread. This rev ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · 2008
Featured Publication
Androgen-deprivation therapy, a mainstay in the treatment of locally advanced and metastatic prostate cancer, is associated with significant bone loss and related complications, such as fracture. Bisphosphonates, osteoclast inhibitors, are effective in pre ...
Full textLink to itemCite
Journal ArticleClin Trials · 2008
Featured Publication
BACKGROUND: The time between the diagnosis of cancer and a planned definitive surgical procedure offers a strong and direct approach for assessing the impact of interventions (including lifestyle interventions) on the biology of the target tissue and the t ...
Full textLink to itemCite
Journal ArticleTherapy · January 1, 2008
At present, the treatment paradigm for localized prostate cancer (PCa) is to distinguish patients with clinically relevant cancers who require treatment either in the form of traditional radical therapy or a contemporary less aggressive, organ-preserving a ...
Full textCite
ConferenceProceedings - IEEE Ultrasonics Symposium · January 1, 2008
We are investigating utilizing ARFI imaging to guide prostate needle biopsy. Our previous ex vivo study demonstrated that ARFI imaging using a VF10-5 linear array was able to visualize the internal anatomy and suspicious lesions in the prostate, which may ...
Full textCite
Journal ArticleTechnol Cancer Res Treat · December 2007
Featured Publication
Between September 2000 and September 2006, 26 patients underwent primary laparoscopic cryosurgical procedures (28) for an organ-confined renal tumor(s). In one case, cryosurgery was done sequentially on both kidneys. All patients had been carefully selecte ...
Full textLink to itemCite
Journal ArticleUrology · December 2007
Featured Publication
OBJECTIVES: To evaluate biologic behaviors of unilateral cancers compared with bilateral cancers on prostate-specific antigen (PSA) recurrence after radical prostatectomy. METHODS: Analysis included demographic, clinical, and pathologic parameters of 1184 ...
Full textLink to itemCite
ConferenceProceedings - IEEE Ultrasonics Symposium · December 1, 2007
McNeal's zonal anatomy for prostate has been the standard anatomical model for human prostate for about 30 years. It divides a human prostate into one non-glandular zone (the anterior flbromuscular stroma), and three glandular zones (central zone (CZ), tra ...
Full textCite
Journal ArticleCancer · August 15, 2007
Featured Publication
BACKGROUND: Early detection of small-volume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organ-sparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporar ...
Full textLink to itemCite
Journal ArticleCan J Urol · August 2007
Featured Publication
Prostatic abscess is a rare and potentially life-threatening disease when left untreated. We report the first case of a man who developed a prostatic abscess as a long-term complication of cryoablation for primary prostate cancer. Timely diagnosis with non ...
Link to itemCite
Journal ArticleUrology · July 2007
Featured Publication
OBJECTIVES: Percutaneous perineal cryoablation of the prostate is a promising technique in the treatment armamentarium for clinically localized prostate carcinoma. We report our initial experience using a transrectal ultrasound-guided, third-generation, ar ...
Full textLink to itemCite
Journal ArticleUrology · May 2007
Featured Publication
Percutaneous radiofrequency ablation is a minimally invasive treatment that is currently used to treat renal tumors. Despite its minimally invasive nature, potential serious complications can occur. We report the second case of ureteropelvic junction obstr ...
Full textLink to itemCite
Journal ArticleUrology · May 2007
Featured Publication
OBJECTIVES: To describe 6 cases of rectourethral fistula in patients treated with brachytherapy plus external beam radiotherapy for localized prostate cancer and subsequent rectal biopsies or rectal surgery. METHODS: A retrospective chart review was undert ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · April 2007
Featured Publication
In total, 1386 paraffin embedded radical prostatectomy specimens from patients with clinically localized prostate cancer (PCa) excised between 2002-06 were analyzed. Pathologic assessment paid particular attention to laterality and percentage of tumor invo ...
Full textLink to itemCite
Journal ArticleJ Urol · April 2007
Featured Publication
PURPOSE: We determined the potential influence of an early adopter bias in patients undergoing robot assisted laparoscopic prostatectomy. MATERIALS AND METHODS: We compared baseline demographic, clinical and health related quality of life characteristics o ...
Full textLink to itemCite
Journal ArticleBJU Int · April 2007
Featured Publication
OBJECTIVE: To identify threshold values of prostate-specific antigen (PSA) levels and PSA velocity (PSAV) to optimize the assessment of the risk of prostate cancer in young men, as prostate cancer is detected increasingly in men aged <50 years. PATIENTS AN ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · April 2007
The techniques of present-day cryosurgery performed with multiprobe freezing apparatus and advanced imaging techniques yield predictable and encouraging results in the treatment of prostatic and renal cancers. Nevertheless, and not unique to cryosurgical t ...
Full textLink to itemCite
Journal ArticleEur Urol · March 2007
Featured Publication
OBJECTIVE: We analysed total hospital costs by comparing minimally invasive surgery (MIS) procedures, such as laparoscopic cryoablation (LCA), laparoscopic partial nephrectomy (LPN), and hand-assisted laparoscopic nephrectomy (HALN), with conventional surg ...
Full textLink to itemCite
Journal ArticleEur Urol · February 2007
Featured Publication
OBJECTIVES: In the current era, minimally invasive surgery using ablative techniques for the treatment of small renal tumours has become a more common and feasible treatment option. In this review, we present recent data regarding the utility of needle abl ...
Full textLink to itemCite
Journal ArticleUrology · February 2007
Featured Publication
OBJECTIVES: To evaluate the financial implications of how the costs of new minimally invasive surgery such as laparoscopic robotic prostatectomy (LRP) and cryosurgical ablation of the prostate (CAP) technologies compare with those of conventional surgery. ...
Full textLink to itemCite
Journal ArticleJ Urol · February 2007
Featured Publication
PURPOSE: We identified age adjusted prostate specific antigen and prostate specific antigen velocity cut points for prostate cancer biopsy. MATERIALS AND METHODS: A cohort of 33,643 men was retrieved from the Duke Prostate Center database. Of this group 11 ...
Full textLink to itemCite
Journal ArticleCan J Urol · December 2006
Featured Publication
AIM: To describe a malignant cystic nephroma in an asymptomatic man. METHODS: Case report and review of the literature. RESULTS: A 60 year old white male presented with an incidentally discovered right perirenal mass. An MRI demonstrated a large perinephri ...
Link to itemCite
Journal ArticleUrology · December 2006
Featured Publication
Patients with metachronous bilateral renal cell carcinoma pose a significant challenge given the high mortality of renal cell carcinoma and the poor quality of life should dialysis become necessary. In addition, patients may be subject to morbidity due to ...
Full textLink to itemCite
Journal ArticleJ Endourol · December 2006
Featured Publication
BACKGROUND AND PURPOSE: Cryotherapy provides a minimally invasive treatment for small renal tumors via an open, percutaneous, or laparoscopic approach. We sought to determine the most appropriate duration of freezing and the number of probes necessary to p ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · May 2006
Featured Publication
PURPOSE OF REVIEW: With the recent introduction of novel, minimally invasive procedures for the treatment of prostate cancer, cryotherapy has become a feasible option as a viable alternative to traditional radical surgery and radiation therapy. In this rev ...
Full textLink to itemCite
Journal ArticleUrology · May 2006
Featured Publication
Obstruction of the urinary collecting system in pregnant women can present a unique challenge to the urologist. Although ureteral obstruction due to stone disease is well-documented and ureteral obstruction is a well-known and defined cause of acute renal ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · 2006
Featured Publication
Salvage treatment for recurrent prostate cancer remains a very difficult and challenging field in urologic oncology. The introduction of minimally invasive surgical procedures such a targeted cryoablation brings some hope with its feasibility and efficacy ...
Full textLink to itemCite
Journal ArticleEuropean Urology, Supplements · January 1, 2006
Objectives: To debate the different laparoscopic approaches for the surgical management of patients with circumcaval ureter. Methods: Updated literature review and discussion of personal experiences concerning the laparoscopic treatment of the circumcaval ...
Full textCite
Journal ArticleUrology · December 2005
Featured Publication
OBJECTIVES: To evaluate our experience with percutaneous radiofrequency ablation (pRFA) to determine common characteristics of patients with complications, to elucidate possible relative contraindications to therapy. METHODS: Medical records of all patient ...
Full textLink to itemCite
Journal ArticleUrology · November 2005
Featured Publication
OBJECTIVES: To evaluate the efficacy and safety of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases who were receiving androgen deprivation therapy. METHODS: Patients received zoledronic acid 4 ...
Full textLink to itemCite
Journal ArticleUrology · July 2005
Featured Publication
OBJECTIVES: To characterize supplement use within a sample population of men diagnosed with prostate cancer. METHODS: A census of men diagnosed with prostate cancer at Duke University Medical Center from 1997 to 2002 (n = 1402) was mailed a survey that asc ...
Full textLink to itemCite
Journal ArticleJ Urol · June 2005
Featured Publication
PURPOSE: Although ablative technologies, including radio frequency (RF) ablation (RFA) and cryoablation (CA), are being used to treat renal masses, complications associated with injury to vital renal structures are not well understood. We investigated thes ...
Full textLink to itemCite
Journal ArticleUrology · February 2005
Featured Publication
OBJECTIVES: To determine the effect of prior benign prostate biopsies on the surgical and clinical outcomes of patients treated with radical perineal prostatectomy for prostate cancer. METHODS: A total of 1369 patients with clinically localized prostate ca ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · June 15, 2004
Featured Publication
PURPOSE: Promoter hypermethylation is an important mechanism of inactivation of tumor suppressor genes in cancer cells. Kidney tumors are heterogeneous in their histology, genetics, and clinical behavior. To gain insight into the role of epigenetic silenci ...
Full textLink to itemCite
Journal ArticleUrology · May 2004
Featured Publication
OBJECTIVES: Dietary factors may influence the prostate and have an impact on prostatic growth and disease. A small number of studies have suggested that flaxseed-supplemented, fat-restricted diets may thwart prostate cancer growth in both animals and human ...
Full textLink to itemCite
Journal ArticleUrology · May 2003
Featured Publication
An 86-year-old woman with a previous excision of a large retroperitoneal low-grade liposarcoma presented with a 4-month history of persistent left flank discomfort. Workup revealed left hydronephrosis secondary to obstruction, which was caused by a recurre ...
Full textLink to itemCite
Journal ArticleJ Endourol · April 2003
Featured Publication
BACKGROUND AND PURPOSE: Surgical clips are commonly employed during laparoscopic radical nephrectomy to ligate perihilar vessels reliably, yet these clips can interfere with the application of a vascular stapler to major vessels, potentially leading to cat ...
Full textLink to itemCite
Journal ArticleJ Urol · July 2002
Featured Publication
PURPOSE: Positron emission tomography (PET) imaging is used for the metabolic evaluation of cancer. [18F]fluorodeoxyglucose (FDG) is commonly used as a radiotracer but its low cellular uptake rate in prostate cancer limits its usefulness. We evaluated the ...
Link to itemCite
Journal ArticleUrology · July 2002
Featured Publication
OBJECTIVES: The increased incidental detection of small (less than 4 cm) renal tumors has stimulated investigations of minimally invasive therapies. Radiofrequency energy is a relatively new and evolving technology that has been used for a variety of exper ...
Full textLink to itemCite
Journal ArticleCancer · February 15, 2002
Featured Publication
BACKGROUND: Despite the ability of radical prostatectomy to eradicate prostate carcinoma, biochemical evidence of recurrent prostate carcinoma may be seen in approximately 40% of patients 15 years after they undergo surgery. Localization of recurrent disea ...
Link to itemCite
Journal ArticleUrology · July 2001
Featured Publication
OBJECTIVES: Dietary fat and fiber affect hormonal levels and may influence cancer progression. Flaxseed is a rich source of lignan and omega-3 fatty acids and may thwart prostate cancer. The potential effects of flaxseed may be enhanced with concomitant fa ...
Full textLink to itemCite
Journal ArticleAm J Med · May 2001
Featured Publication
The incidental finding of a small renal mass poses a therapeutic dilemma. The traditional treatment of clinically important masses has been radical nephrectomy. Recently, nephron-sparing surgery has emerged as a viable alternative; and experimental minimal ...
Full textLink to itemCite
Journal ArticleTech Urol · March 2001
Featured Publication
PURPOSE: Capromab pendetide (ProstaScint) is an indium In 111 ((111)In)-labeled monoclonal antibody to prostate-specific membrane antigen (PSMA) used to image prostate cancer. The appropriate techniques for obtaining images with this modality and the appro ...
Link to itemCite
Journal ArticleCancer Res · January 1, 2001
Featured Publication
The up-regulation of rates of choline uptake and phosphorylation in certain malignancies has motivated the development of positron-labeled choline analogues for noninvasive detection of cancer using positron emission tomography (PET). The choline analogue, ...
Link to itemCite
Journal ArticleUrology · June 2000
Featured Publication
OBJECTIVES: Laparoscopy may be complicated by neuromuscular injuries, both to the patient and to the surgeon. We used a survey to estimate the incidence of these injuries during urologic laparoscopic surgery, to assess risk factors for these injuries, and ...
Full textLink to itemCite
Journal ArticleCancer Biother Radiopharm · April 2000
Featured Publication
Capromab Pendetide imaging illustrates the successful translation of monoclonal antibody technology from the laboratory to the clinic. It provides a means of identifying otherwise occult soft tissue metastases in patients with adenocarcinoma of the prostat ...
Full textLink to itemCite
Journal ArticleJ Urol · August 1999
Featured Publication
PURPOSE: Many advances have occurred during the last decade in the clinical use of prostate specific antigen (PSA) for detecting, staging and monitoring prostate cancer. We review the clinical usefulness and limitations of serum PSA as a tumor marker of pr ...
Full textLink to itemCite
Journal ArticleCancer · April 1, 1999
Featured Publication
BACKGROUND: The pretherapy prediction of occult lymph node involvement and the avoidance of otherwise futile and potentially morbid definitive local therapy is paramount in men with newly diagnosed prostate carcinoma. To identify patients with prostate car ...
Link to itemCite
Journal ArticleUrology · March 1999
Featured Publication
ObjectivesTo evaluate the efficacy of interstitial saline radiofrequency energy for reproducibly ablating nonmalignant (control) and malignant (the VX-2 tumor) renal tissue in a rabbit model, and to determine the ability of conventional gray-scale ...
Full textCite
Journal ArticleProstate Cancer Prostatic Dis · December 1998
Featured Publication
To benefit from definitive local therapy, men with clinically localized prostate cancer should have organ-confined disease. We discuss the use of multivariate analysis using serum PSA, biopsy Gleason score and clinical stage to improve the prediction of pa ...
Full textLink to itemCite
Journal ArticleUrology · December 1998
Featured Publication
OBJECTIVES: Previous reports indicate that up to 10% of patients with localized renal cell carcinoma have direct intracaval neoplastic extension. Many patients with locally confined tumors and small intracaval tumor extensions can be surgically cured. Few ...
Full textLink to itemCite
Journal ArticleSemin Urol Oncol · August 1998
Featured Publication
The patient presented is a 58-year-old man with newly diagnosed prostate cancer who likely has at least a 10- to 15-year life expectancy. In staging this man's extent of disease, several preoperative clinical variables are provided to assess whether the pa ...
Link to itemCite
Journal ArticleUrology · June 1998
Featured Publication
OBJECTIVES: To evaluate the relative efficacy of brachytherapy to radical prostatectomy, we compared biochemical progression rates from a published series of men who underwent iodine 125 (125I) interstitial radiotherapy for localized prostate cancer to a s ...
Link to itemCite
OtherBritish Journal of Urology · December 1, 1997
Purpose: Four to ten percent of patients with renal cell carcinoma have direct extension of tumor into the inferior vena cava. Although many patients, particularly those with locally confined lesions and small intracaval tumor extensions, may be surgical c ...
Cite
OtherBritish Journal of Urology · December 1, 1997
Small renal tumors are being discovered more commonly because of frequent radiologie examinations for a variety of symptoms. Partial nephrectomy rather than radical nephrectomy has been considered in many of these patients in order to conserve renal tissue ...
Cite
Journal ArticleCancer Res · November 1, 1996
Featured Publication
Collecting duct carcinoma (CDC) of the kidney is a rare malignant neoplasm of distal nephron origin. Previous studies of CDC have shown loss of heterozygosity on chromosomal arm 1q in 57% of the cases studied. To better characterize 1q loss in CDC, we perf ...
Link to itemCite
Journal ArticleJ Urol · August 1996
Featured Publication
PURPOSE: We retrospectively evaluated the ability of human chorionic gonadotropin (HCG) to make the nonpalpable cryptorchid testis become palpable and promote testicular descent. MATERIALS AND METHODS: Through surgical bookings we identified 94 patients yo ...
Full textLink to itemCite
Journal ArticleCancer Res · April 15, 1996
Featured Publication
Tumors of varying malignant potential arise from the complex epithelial lining of the nephron. Although the molecular characteristics of renal clear cell carcinomas, which arise from the proximal tubule, have been studied, little is known about tumors that ...
Link to itemCite
Journal ArticleCancer Res · November 15, 1995
Featured Publication
Accumulating evidence implicates the presence of putative tumor suppressor genes on human chromosome 4 that are potentially inactivated in the genesis of several different neoplasms. To accurately determine the frequency of allelic loss on both arms of hum ...
Link to itemCite
Journal ArticleJ Urol · November 1995
Featured Publication
PURPOSE: Intraoperative sonography was used to evaluate prospectively the renal parenchyma of patients undergoing surgery for presumed renal neoplasia. MATERIALS AND METHODS: One surgeon (F.F.M.) evaluated 100 kidneys using a triple-head sector ultrasonic ...
Link to itemCite
Journal ArticleJ Urol · October 1995
Featured Publication
PURPOSE: We evaluate whether partial nephrectomy can be performed safely and efficaciously for renal tumors. MATERIALS AND METHODS: The results of 67 partial nephrectomies performed between 1977 and 1994 for renal cell carcinoma (51), oncocytoma (9), angio ...
Full textLink to itemCite
Journal ArticleNat Genet · October 1995
Featured Publication
Many tumour types have been reported to have deletion of 9p21 (refs 1-6). A candidate target suppressor gene, p16 (p16INK4a/MTS-1/CDKN2), was recently identified within the commonly deleted region in tumour cell lines. An increasing and sometimes conflicti ...
Full textLink to itemCite
Journal ArticleCancer Res · August 1, 1995
Featured Publication
Two hundred eighty-five primary human carcinomas of the urinary bladder were examined for allelic loss on chromosome 14q. Seventeen highly polymorphic dinucleotide markers spanning the long arm of this acrocentric chromosome were selected for fine PCR-base ...
Link to itemCite
Journal ArticleJ Urol · July 1995
Featured Publication
Arterial insufficiency is a major factor responsible for impotence in men following nerve sparing radical prostatectomy. Previously, accessory internal pudendal arteries have been identified traveling over the anterolateral surface of the prostate. Based o ...
Full textLink to itemCite
Journal ArticleUrology · April 1995
Featured Publication
OBJECTIVES: Laparoscopic retropubic urethropexy has recently been described as an alternative method to the surgical correction of pure stress urinary incontinence. This study compares the operative technique and results of laparoscopic colposuspension wit ...
Full textLink to itemCite
Journal ArticleUrol Oncol · 1995
Featured Publication
We studied the effect of age on tumor progression (defined as postoperative prostate specific antigen elevation) in 543 men who underwent radical prostatectomy for clinically localized prostate cancer. Patients were divided into two age groups: patients un ...
Full textLink to itemCite
Journal ArticleJournal of Human Hypertension · December 1990
To test the hypothesis that the combination of a calcium antagonist and diuretic is less effective in lowering BP than the combination of ACE inhibitor plus diuretic, we compared two groups of patients. The first was a group of 157 consecutive patients (32 ...
Cite
Journal ArticleBiochemical Journal · May 1, 1987
High concentrations of neomycin (2-10 mM) inhibited aggregation, but not shape change, of intact platelets by collagen, ADP and the Ca2+ ionophore, A23187, the last two studies being carried out in the presence of the cyclo-oxygenase inhibitor indo ...
Full textCite